Australia markets open in 5 hours 14 minutes

Mayne Pharma Group Limited (MYX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
7.270.00 (0.00%)
At close: 04:10PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from investing activities
Investments in property, plant and equipment
-19,452
-219,585
-11,853
-25,097
-47,118
Purchases of investments
-475
-127,526
-
-
-
Other investing activities
-14,739
-34,671
-21,840
-24,150
-8,755
Net cash used for investing activities
62,657
473,485
-28,526
-49,247
-55,873
Cash flows from financing activities
Debt repayment
-131,571
-598,578
-176,517
-222,255
-203,404
Common stock issued
7,053
-
-
-
72
Common stock repurchased
-
-6,223
-
-
-
Dividends paid
-
-45,292
-
-
-
Other financing activities
22
-1,596
-2,313
-2,322
-3,896
Net cash used provided by (used for) financing activities
-113,267
-431,886
27,601
-40,440
4,523
Net change in cash
-65,234
-1,113
-8,131
-30,825
48,427
Cash at beginning of period
175,541
96,672
97,980
137,785
89,004
Cash at end of period
110,307
92,616
96,672
97,980
137,785
Free cash flow
Capital expenditure
-19,452
-219,585
-11,853
-25,097
-47,118
Free cash flow
-34,076
-262,297
-19,059
33,765
52,659